Daily Dose

The Latest Health News

Latest

Bladder Cancer vs. Bladder Infection: A Test That Shows the Difference

Researchers in Germany have found a way to detect a biomarker for bladder cancer (AHNAK2), as opposed to a bladder infection, for the first time.

By Diane Domina

If You Eat a Lot of Highly-Processed Foods, Read This

Each 10 percent increase in the amount of ultra-processed food you eat can raise your risk of an earlier death by about 14 percent, say French researchers.

By Diane Domina

FDA Steps Up Efforts to Regulate Dietary Supplements

The FDA ust announced the most significant change in dietary supplement regulation since the Dietary Supplement Health and Education Act more than 25 years ago.

By Diane Domina

Dizzy When You Stand Up? Too Much Sodium or Too Little?

A study conducted in Boston suggests increasing salt intake, the standard intervention to prevent dizziness upon standing, may instead raise the risk.

By Diane Domina

Cardiac MRI Can Detect Dangerous Heart Disease

Cardiac magnetic resonance imaging may be a non-invasive alternative to stress echocardiogram and catheterization to assess coronary artery disease severity.

By Diane Domina

Ditch This Hangover Advice

Hangovers are the same whether you drink beer before wine or the other way around, according to a study in the American Journal of Clinical Nutrition.

By Diane Domina

High-Risk HPV Linked to Heart Disease

High-risk strains of HPV linked to cancer may also be associated with cardiovascular disease, according to a study.

By Diane Domina

Fibromyalgia: Misdiagnosis Rates Are High

There’s disagreement between fibromyalgia diagnoses in the U.S and established diagnostic criteria for the condition — many people told they have it may not.

By Diane Domina

Gastric Bypass: A Silver Bullet for Diabetes Remission?

About three-fourths of people with type 2 diabetes who had Roux-en-Y gastric bypass surgery experienced remission of their diabetes within a year.

By Diane Domina

An Algorithm That Can Identify High-Risk Prostate Cancer

Researchers have been working on a tool that can identify low- and high-risk prostate cancer more accurately.

By Diane Domina